Jean-Jacques GOY

Prof. Dr. Jean-Jacques GOY


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2005 in JACC
Verified
Journal Article
Closed access
JGJean-Jacques GOY
Jean-Jacques GOY
JSJean-Christophe Stauffer
Jean-Christophe Stauffer
MSManon Siegenthaler
Manon Siegenthaler
ABAlain Benoît
Alain Benoît
CSCharles Seydoux
Charles Seydoux

1 September 2008 in JACC
Verified
Journal Article
Closed access
JGJean-Jacques GOY
Jean-Jacques GOY
UKUrs Kaufmann
Urs Kaufmann
MHMichel Hurni
Michel Hurni
SCStéphane Cook
Stéphane Cook
Francesco VersaciFrancesco Versaci
Francesco Versaci
EEEric Eeckhout
Eric Eeckhout

12 May 2017 in International Journal of Cardiology
Verified
Journal Article
Closed access
PDF file
DADiego Arroyo
Diego Arroyo
GGGregoire Gendre
Gregoire Gendre
SSSara Schukraft
Sara Schukraft
ZKZacharenia Kallinikou
Zacharenia Kallinikou
OMOlivier Müller
Olivier Müller
SPSerban Puricel
Serban Puricel

1 July 2016 in The American Journal of Cardiology
Verified
Journal Article
Closed access
ZKZacharenia Kallinikou
Zacharenia Kallinikou
SPSerban G. Puricel
Serban G. Puricel
NRNick Ryckx
Nick Ryckx
MTMario Togni
Mario Togni
GBGerard Baeriswyl
Gerard Baeriswyl
JGJean-Jacques GOY
Jean-Jacques GOY

30 November 2020 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
SMSrinivasan Murali
Srinivasan Murali
NBNicolas Brugger
Nicolas Brugger
FRFrancisco Rincon
Francisco Rincon
MMManoj Mashru
Manoj Mashru
SCStéphane Cook
Stéphane Cook
JGJean-Jacques GOY
Jean-Jacques GOY
Background: Cardiac arrhythmias are very common but underdiagnosed due to their transient and asymptomatic nature. An optimization of arrhythmia detection would permit to better treat patients and could substantially reduce morbidity and mortality. The SmartCardia ScaAI wireless patch is a novel CE IIa approved, single-lead electrocardiographic (ECG) ambulatory monitor designed for cardiac arrhythmias detection.Hypothesis: The accuracy of the new SmartCardia wireless patch to detect arrhythmias is comparable to the conventional Holter monitoring.Methods: Patients referred for a suspicion of arrhythmia between February and March 2020 were included in the trial. Simultaneous ambulatory ECG were recorded using a conventional 24-h Holter and the SmartCardia. The primary endpoint was the detection of cardiac arrhythmias over the total wear time of the devices, defined as premature atrial contraction (PAC), supraventricular tachycardia ≥3 beats, premature ventricular contraction (PVC), and ventricular tachycardia ≥3 beats. Conduction abnormalities, pause ≥2 s and atrioventricular block (AVB), were also tracked. McNemar's test was used to compare the matched pairs of data from both devices.Results: A total of 40 patients were included in the trial. Over the total wear time, there was no significant difference between the devices for ventricular and supraventricular arrhythmias detection. Pauses and AVB were equally identified by the two devices in three patients.Conclusion: Over the total wear time, the SmartCardia device showed an accuracy to detect arrhythmia similar to the 24-h Holter monitoring: single-lead, adhesive-patch monitoring might become an interesting alternative to the conventional Holter monitoring.

22 April 2020 in JMIR Biomedical Engineering
Verified
Journal Article
Open access
SMSrinivasan Murali
Srinivasan Murali
FRFrancisco Rincon
Francisco Rincon
TCTiziano Cassina
Tiziano Cassina
SCStéphane Cook
Stéphane Cook
JGJean-Jacques GOY
Jean-Jacques GOY
Background: Continuous cardiac monitoring with wireless sensors is an attractive option for early detection of arrhythmia and conduction disturbances and the prevention of adverse events leading to patient deterioration. We present a new sensor design (SmartCardia), a wearable wireless biosensor patch, for continuous cardiac and oxygen saturation (SpO2) monitoring. Objective: This study aimed to test the clinical value of a new wireless sensor device (SmartCardia) and its usefulness in monitoring the heart rate (HR) and SpO2 of patients. Methods: We performed an observational study and monitored the HR and SpO2 of patients admitted to the intensive care unit (ICU). We compared the device under test (SmartCardia) with the ICU-grade monitoring system (Dräger-Healthcare). We defined optimal correlation between the gold standard and the wireless system as <10% difference for HR and <4% difference for SpO2. Data loss and discrepancy between the two systems were critically analyzed. Results: A total of 58 ICU patients (42 men and 16 women), with a mean age of 71 years (SD 11), were included in this study. A total of 13.49 (SD 5.53) hours per patient were recorded. This represents a total recorded period of 782.3 hours. The mean difference between the HR detected by the SmartCardia patch and the ICU monitor was 5.87 (SD 16.01) beats per minute (bias=–5.66, SD 16.09). For SpO2, the average difference was 3.54% (SD 3.86; bias=2.9, SD 4.36) for interpretable values. SmartCardia’s patch measures SpO2 only under low-to-no activity conditions and otherwise does not report a value. Data loss and noninterpretable values of SpO2 represented 26% (SD 24) of total measurements. Conclusions: The SmartCardia device demonstrated clinically acceptable accuracy for HR and SpO2 monitoring in ICU patients.